In colorectal cancer (CRC) cells the SphK inhibitor PF-543 provoked programmed necrosis cascade by inducing mitochondrial p53-CyPD association, mitochondrial membrane potential reduction and the release of LDH to the medium. This evidence concerns the gene TP53 and colorectal carcinoma.